Teva Slams Lilly's 'Scorched-Earth' Tactics In Migraine Battle

By Brian Dowling · February 10, 2023, 12:53 PM EST

Teva Pharmaceuticals urged a Boston federal judge to triple the $176.5 million verdict it won after convincing a jury that Eli Lilly & Co. infringed three of its migraine drug patents...

To view the full article, register now.

Documents

Case Information

Case Title

Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

Case Number

1:18-cv-12029

Court

Massachusetts

Nature of Suit

Patent

Date Filed

September 27, 2018